APA (7th ed.) Citation

Farach, L. S., Richard, M. A., Wulsin, A. C., Bebin, E. M., Krueger, D. A., Sahin, M., . . . Cutter, G. (2024). Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial. Pediatric Neurology, 159, 62. https://doi.org/10.1016/j.pediatrneurol.2024.06.012

Chicago Style (17th ed.) Citation

Farach, Laura S., et al. "Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial." Pediatric Neurology 159 (2024): 62. https://doi.org/10.1016/j.pediatrneurol.2024.06.012.

MLA (9th ed.) Citation

Farach, Laura S., et al. "Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial." Pediatric Neurology, vol. 159, 2024, p. 62, https://doi.org/10.1016/j.pediatrneurol.2024.06.012.